Establishing computed tomography-defined visceral fat area thresholds for use in obesity-related cancer research

Nutrition Research

Volumn 33, Issue 3, 2013, Pages 171-179

  Doyle, Suzanne L ^a   Bennett, Anne Marie ^a   Donohoe, Claire L ^a   Mongan, Ann Marie ^a   Howard, Julia M ^b   Lithander, Fiona E ^b,c   Pidgeon, Graham P ^a   Reynolds, John V ^a   Lysaght, Joanne ^a  

^a Dublin Molecular Medicine Centre   (Ireland)

^b ST JAMES S HOSPITAL   (Ireland)

^c Biology and Environment   (Australia)

Author keywords

Computed tomography; Gastrointestinal cancer; Receiver operating characteristic; The metabolic syndrome; Visceral adipose tissue

Indexed keywords

ABDOMINAL OBESITY; ACCURACY; ADULT; AGED; ANALYTICAL PARAMETERS; ARTICLE; CANCER PATIENT; CANCER RESEARCH; COHORT ANALYSIS; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CUT OFF VALUE; DIAGNOSTIC TEST ACCURACY STUDY; DIGESTIVE SYSTEM CANCER; FEMALE; GASTROINTESTINAL SURGERY; HUMAN; IMAGING SOFTWARE; INTRAABDOMINAL FAT; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE; SUBCUTANEOUS FAT; WAIST CIRCUMFERENCE;

ADULT; AGED; AGED, 80 AND OVER; BODY MASS INDEX; COHORT STUDIES; FEMALE; GASTROINTESTINAL NEOPLASMS; HUMANS; INTRA-ABDOMINAL FAT; MALE; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; REFERENCE VALUES; RISK FACTORS; ROC CURVE; SENSITIVITY AND SPECIFICITY; SEX FACTORS; TOMOGRAPHY, X-RAY COMPUTED; WAIST CIRCUMFERENCE;

EID: 84875379472     PISSN: 02715317     EISSN: 18790739     Source Type: Journal    
DOI: 10.1016/j.nutres.2012.12.007     Document Type: Article

References (52)

1. Bessesen D.H. Update on obesity. J Clin Endocrinol Metabol 2008, 93:2027-2034.
2. Donohoe C.L., Pidgeon G.P., Lysaght J., Reynolds J.V. Obesity and gastrointestinal cancer. Br J Surg 2010, 97:628-642.
3. Kershaw E.E., Flier J.S. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004, 89:2548-2556.
4. Galic S., Oakhill J.S., Steinberg G.R. Adipose tissue as an endocrine organ. Mol Cell Endocrinol 2010, 316:129-139.
5. Dietze-Schroeder D., Sell H., Uhlig M., Koenen M., Eckel J. Autocrine action of adiponectin on human fat cells prevents the release of insulin resistance-inducing factors. Diabetes 2005, 54:2003-2011.
6. Alberti K.G.M.M., Zimmet P., Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med 2006, 23:469-480.
7. Fujioka S., Matsuzawa Y., Tokunaga K., Tarui S. Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity. Metabolism 1987, 36:54-59.
8. World Health Organisation (WHO) Physical status: the use and interpretation of anthropometry. Report of a WHO Expert Committee. World Health Organ Tech Rep Ser 1995, 854.
9. Lean M.E.J., Han T.S., Morrison C.E. Waist circumference as a measure for indicating need for weight management. BMJ 1995, 311:158-161.
10. Okorodudu D.O., Jumean M.F., Montori V.M., Romero-Corral A., Somers V.K., Erwin P.J., et al. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes 2010, 34:791-799.
11. Oka R., Kobayashi J., Yagi K., Tanii H., Miyamoto S., Asano A., et al. Reassessment of the cutoff values of waist circumference and visceral fat area for identifying Japanese subjects at risk for the metabolic syndrome. Diabetes Res Clin Pract 2008, 79:474-481.
12. Klopfenstein B.J., Kim M.S., Krisky C.M., Szumowski J., Rooney W.D., Purnell J.Q. Comparison of 3 T MRI and CT for the measurement of visceral and subcutaneous adipose tissue in humans. Br J Radiol 2012, 85:e826-e830.
13. Doyle S.L., Donohoe C.L., Lysaght J., Reynolds J.V. Visceral obesity, metabolic syndrome, insulin resistance and cancer. Proc Nut Soc 2012, 71:181-189.
14. Allott E.H., Lysaght J., Cathcart M.C., Donohoe C.L., Cummins R., McGarrigle S.A., et al. MMP9 expression in oesophageal adenocarcinoma is upregulated with visceral obesity and is associated with poor tumour differentiation. Mol Carcinog 2011, 52:144-154.
15. Pou K.M., Massaro J.M., Hoffmann U., Vasan R.S., Maurovich-Horvat P., Larson M.G., et al. Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: The Framingham Heart Study. Circulation 2007, 116:1234-1241.
16. Takahashi H., Takayama T., Yoneda K., Endo H., Iida H., Sugiyama M., et al. Association of visceral fat accumulation and plasma adiponectin with rectal dysplastic aberrant crypt foci in a clinical population. Cancer Sci 2009, 100:29-32.
17. Ohki T., Tateishi R., Shiina S., Goto E., Sato T., Nakagawa H., et al. Visceral fat accumulation is an independent risk factor for hepatocellular carcinoma recurrence after curative treatment in patients with suspected NASH. Gut 2009, 58:839-844.
18. Pouliot M.-C., Després J.-P., Nadeau A., Moorjani S., Prud'Homme D., Lupien P.J., et al. Visceral obesity in men: associations with glucose tolerance, plasma insulin, and lipoprotein levels. Diabetes 1992, 41:826-834.
19. Guiu B., Petit J.M., Bonnetain F., Ladoire S., Guiu S., Cercueil J.-P., et al. Visceral fat area is an independent predictive biomarker of outcome after first-line bevacizumab-based treatment in metastatic colorectal cancer. Gut 2010, 59:341-347.
20. Steffens S., Grünwald V., Ringe K.I., Seidel C., Eggers H., Schrader M., et al. Does obesity influence the prognosis of metastatic renal cell carcinoma in patients treated with vascular endothelial growth factor-targeted therapy?. Oncologist 2011, 16:1565-1571.
21. Despres J.P., Lamarche B. Effects of diet and physical activity on adiposity and body fat distribution: implications for the prevention of cardiovascular disease. Nutr Res Rev 1993, 6:137-159.
22. Hunter G.R., Snyder S.W., Kekes-Szabo T., Nicholson C., Berland L. Intra-abdominal adipose tissue values associated with risk of possessing elevated blood lipids and blood pressure. Obes Res 1994, 2:563-568.
23. Bjorntorp P. Abdominal obesity and the metabolic syndrome. Ann Med 1992, 24:465-468.
24. Bjorntorp P. Metabolic difference between visceral fat and subcutaneous abdominal fat. Diabetes Metab 2000, 26(Suppl 3):10-12.
25. Flint A.J., Rexrode K.M., Hu F.B., Glynn R.J., Caspard H., Manson J.E., et al. Body mass index, waist circumference, and risk of coronary heart disease: a prospective study among men and women. Obesity Res Clin Pract 2010, 4:e171-e181.
26. Kashihara H., Lee J.S., Kawakubo K., Tamura M., Akabayashi A. Criteria of waist circumference according to computed tomography-measured visceral fat area and the clustering of cardiovascular risk factors. Circ J 2009, 73:1881-1886.
27. Katzmarzyk P.T., Bray G.A., Greenway F.L., Johnson W.D., Newton R.L., Ravussin E., et al. Racial differences in abdominal depot specific adiposity in white and African American adults. Am J Clin Nutr 2010, 91:7-15.
28. Kim J.A., Choi C.J., Yum K.S. Cut-off values of visceral fat area and waist circumference: diagnostic criteria for abdominal obesity in a Korean population. J Korean Med Sci 2006, 21:1048-1053.
29. Rickles A., Iannuzzi J., Mironov O., Deeb A.-P., Sharma A., Fleming F., et al. Visceral obesity and colorectal cancer: are we missing the boat with BMI?. J Gastrointestin Surg 2012, 17:133-143.
30. Baumgartner R.N., Heymsfield S.B., Roche A.F., Bernardino M. Abdominal composition quantified by computed tomography. Am J Clin Nutr 1988, 48:936-945.
31. Miller K.D., Jones E., Yanovski J.A., Shankar R., Feuerstein I., Falloon J. Visceral abdominal-fat accumulation associated with use of indinavir. Lancet 1998, 351:871-875.
32. Beddy P., Howard J., McMahon C., Knox M., de Blacam C., Ravi N., et al. Association of visceral adiposity with oesophageal and junctional adenocarcinomas. Br J Surg 2010, 97:1028-1034.
33. Belghazi J., El Feghali R.N., Moussalem T., Rejdych M., Asmar R.G. Validation of four automatic devices for self-measurement of blood pressure according to the International Protocol of the European Society of Hypertension. Vasc Health Risk Manag 2007, 3:389-400.
34. Youden W.J. Index for rating diagnostic tests. Cancer 1950, 3:32-35.
35. von Hafe P., Pina F., Perez A., Tavares M., Barros H. Visceral fat accumulation as a risk factor for prostate cancer. Obes Res 2004, 12:1930-1935.
36. Doyle S.L., Donohoe C.L., Finn S.P., Howard J.M., Lithander F.E., Reynolds J.V., et al. IGF-1 and its receptor in esophageal cancer: association with adenocarcinoma and visceral obesity. Am J Gastroenterol 2012, 107:196-204.
37. Yamamoto S., Nakagawa T., Matsushita Y., Kusano S., Hayashi T., Irokawa M., et al. Visceral fat area and markers of insulin resistance in relation to colorectal neoplasia. Diabetes Care 2010, 33:184-189.
38. Ford E.S., Giles W.H., Dietz W.H. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287:356-359.
39. Lemieux S., Prud'homme D., Bouchard C., Tremblay A., Despres J.P. A single threshold value of waist girth identifies normal-weight and overweight subjects with excess visceral adipose tissue. Am J Clin Nutr 1996, 64:685-693.
40. Ross R., Aru J., Freeman J., Hudson R., Janssen I. Abdominal adiposity and insulin resistance in obese men. Am J Physiol Endocrinol Metab 2002, 282:e657-e663.
41. Tanaka S., Horimai C., Katsukawa F. Ethnic differences in abdominal visceral fat accumulation between Japanese, African-Americans, and Caucasians: a meta-analysis. Acta Diabetol 2003, 40(Suppl 1):S302-S304.
42. Brochu M., Starling R.D., Tchernof A., Matthews D.E., Garcia-Rubi E., Poehlman E.T. Visceral adipose tissue is an independent correlate of glucose disposal in older obese postmenopausal women. J Clin Endocrinol Metab 2000, 85:2378-2400.
43. Hu G., Tuomilehto J., Silventoinen K., Ne Barengo, Jousilahti P. Joint effects of physical activity, body mass index, waist circumference and waist-to-hip ratio with the risk of cardiovascular disease among middle-aged Finnish men and women. Eur Heart J 2004, 25:2212-2219.
44. Larsson B., Svardsudd K., Welin L., Wilhelmsen L., Bjorntorp P., Tibblin G. Abdominal adipose tissue distribution, obesity, and risk of cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed) 1984, 288:1401-1404.
45. Fox C.S., Massaro J.M., Hoffmann U., Pou K.M., Maurovich-Horvat P., Liu C.-Y., et al. Abdominal visceral and subcutaneous adipose tissue compartments. Circulation 2007, 116:39-48.
46. Alberti K.G.M.M., Eckel R.H., Grundy S.M., Zimmet P.Z., Cleeman J.I., Donato K.A., et al. Harmonizing the metabolic syndrome: A joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 2009, 120:1640-1645.
47. Pouliot M.C., Despres J.P., Lemieux S., Moorjani S., Bouchard C., Tremblay A., et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994, 73:460-468.
48. World Health Organisation (WHO) Obesity preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser 2000, 894i-xii:1-25.
49. Snijder M.B., van Dam R.M., Visser M., Seidell J.C. What aspects of body fat are particularly hazardous and how do we measure them?. Int J Epidemiol 2006, 35:83-92.
50. Balentine C.J., Marshall C., Robinson C., Wilks J., Anaya D., Albo D., et al. Validating quantitative obesity measurements in colorectal cancer patients. J Surg Res 2010, 164:18-22.
51. Park J., Euhus D.M., Scherer P.E. Paracrine and endocrine effects of adipose tissue on cancer development and progression. Endocr Rev 2011, 32:550-570.
52. van Kruijsdijk R.C.M., van der Wall E., Visseren F.L.J. Obesity and cancer: the role of dysfunctional adipose tissue. Cancer Epidemiol Biomarkers Prev 2009, 18:2569-2578.